Hepatic Arterial Chemotherapy: Current and Future Approaches
Seminars in Interventional Radiology · 21.09.2026
DOI: 10.1055/a-2916-2183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Seminars in Interventional Radiology, erschienen am 21.09.2026. Verfasst von Sanjit Datta und 3 weiteren Autor:innen. Die Arbeit nennt 83 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Hepatic malignancies, both primary and metastatic, represent a substantial and growing global burden of disease. The majority of patients present with incurable disease, and systemic therapy alone is often limited by resistance and toxicity. Hepatic artery-directed chemotherapy delivery exploits the dual blood supply of the liver and the high first-pass hepatic extraction of select chemotherapeutic agents to achieve superior regional drug concentrations while minimizing systemic exposure. This review examines three distinct hepatic chemotherapy perfusion strategies: hepatic artery infusion pump therapy (HAIP), percutaneous hepatic artery infusion chemotherapy (PHAIC), and percutaneous hepatic perfusion (PHP). For each modality, we review the mechanistic rationale, technical approach, patient selection criteria, clinical evidence, and associated complications. Collectively, these strategies represent complementary and increasingly validated tools in the multidisciplinary management of hepatic malignancies.
Zitieren
APA
Datta, S., Hoffman, D., Melstrom, L., & Kessler, J. (2026). Hepatic Arterial Chemotherapy: Current and Future Approaches. Seminars in Interventional Radiology. https://doi.org/10.1055/a-2916-2183
Vancouver
Datta S, Hoffman D, Melstrom L, Kessler J. Hepatic Arterial Chemotherapy: Current and Future Approaches. Seminars in Interventional Radiology. 2026. doi:10.1055/a-2916-2183
BibTeX
@article{Datta2026,
author = {Datta, Sanjit and Hoffman, Daniel and Melstrom, Laleh and Kessler, Jonathan},
title = {Hepatic Arterial Chemotherapy: Current and Future Approaches},
journal = {Seminars in Interventional Radiology},
year = {2026},
doi = {10.1055/a-2916-2183}
}
EUVIMED